HEADER LIGASE/ISOMERASE/PROTEIN BINDING 05-NOV-11 3UIO TITLE COMPLEX BETWEEN HUMAN RANGAP1-SUMO2, UBC9 AND THE IR1 DOMAIN FROM TITLE 2 RANBP2 CONTAINING IR2 MOTIF II COMPND MOL_ID: 1; COMPND 2 MOLECULE: SUMO-CONJUGATING ENZYME UBC9; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SUMO-PROTEIN LIGASE, UBIQUITIN CARRIER PROTEIN 9, UBIQUITIN COMPND 5 CARRIER PROTEIN I, UBIQUITIN-CONJUGATING ENZYME E2 I, UBIQUITIN- COMPND 6 PROTEIN LIGASE I, P18; COMPND 7 EC: 6.3.2.-; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: SMALL UBIQUITIN-RELATED MODIFIER 2; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: UNP RESIDUES 14-93; COMPND 13 SYNONYM: SUMO-2, HSMT3, SMT3 HOMOLOG 2, SUMO-3, SENTRIN-2, UBIQUITIN- COMPND 14 LIKE PROTEIN SMT3A, SMT3A; COMPND 15 ENGINEERED: YES; COMPND 16 MOL_ID: 3; COMPND 17 MOLECULE: RAN GTPASE-ACTIVATING PROTEIN 1; COMPND 18 CHAIN: C; COMPND 19 FRAGMENT: UNP RESIDUES 419-587; COMPND 20 SYNONYM: RANGAP1; COMPND 21 ENGINEERED: YES; COMPND 22 MOL_ID: 4; COMPND 23 MOLECULE: E3 SUMO-PROTEIN LIGASE RANBP2; COMPND 24 CHAIN: D; COMPND 25 FRAGMENT: UNP RESIDUES 2631-2695; COMPND 26 SYNONYM: 358 KDA NUCLEOPORIN, NUCLEAR PORE COMPLEX PROTEIN NUP358, COMPND 27 NUCLEOPORIN NUP358, RAN-BINDING PROTEIN 2, RANBP2, P270; COMPND 28 ENGINEERED: YES; COMPND 29 MUTATION: YES; COMPND 30 OTHER_DETAILS: MOTIF II OF RANBP2 IR1 WAS MUTATED TO IR2 MOTIF II SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: UBC9, UBCE9, UBE2I; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28B; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: SMT3A, SMT3H2, SUMO2; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET28B; SOURCE 21 MOL_ID: 3; SOURCE 22 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 23 ORGANISM_COMMON: HUMAN; SOURCE 24 ORGANISM_TAXID: 9606; SOURCE 25 GENE: KIAA1835, RANGAP1, SD; SOURCE 26 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 27 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 28 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 29 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 30 EXPRESSION_SYSTEM_PLASMID: PSMT3; SOURCE 31 MOL_ID: 4; SOURCE 32 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 33 ORGANISM_COMMON: HUMAN; SOURCE 34 ORGANISM_TAXID: 9606; SOURCE 35 GENE: NUP358, RANBP2; SOURCE 36 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 37 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 38 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 39 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 40 EXPRESSION_SYSTEM_PLASMID: PSMT3 KEYWDS E3, LIGASE, SUMO, UBC9, RANBP2, NUCLEAR PORE COMPLEX, LIGASE- KEYWDS 2 ISOMERASE-PROTEIN BINDING COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.R.GAREAU,D.REVERTER,C.D.LIMA REVDAT 5 13-SEP-23 3UIO 1 SEQADV LINK REVDAT 4 12-NOV-14 3UIO 1 HET HETATM HETNAM HETSYN REVDAT 3 26-JUN-13 3UIO 1 JRNL REVDAT 2 04-JAN-12 3UIO 1 JRNL REVDAT 1 28-DEC-11 3UIO 0 JRNL AUTH J.R.GAREAU,D.REVERTER,C.D.LIMA JRNL TITL DETERMINANTS OF SMALL UBIQUITIN-LIKE MODIFIER 1 (SUMO1) JRNL TITL 2 PROTEIN SPECIFICITY, E3 LIGASE, AND SUMO-RANGAP1 BINDING JRNL TITL 3 ACTIVITIES OF NUCLEOPORIN RANBP2. JRNL REF J.BIOL.CHEM. V. 287 4740 2012 JRNL REFN ISSN 0021-9258 JRNL PMID 22194619 JRNL DOI 10.1074/JBC.M111.321141 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.7.2_869 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.78 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.410 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 23318 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140 REMARK 3 FREE R VALUE TEST SET COUNT : 1198 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.7781 - 5.4061 1.00 2556 140 0.1685 0.1760 REMARK 3 2 5.4061 - 4.2935 1.00 2507 130 0.1657 0.2196 REMARK 3 3 4.2935 - 3.7515 1.00 2460 142 0.1756 0.2409 REMARK 3 4 3.7515 - 3.4088 1.00 2461 124 0.2051 0.2336 REMARK 3 5 3.4088 - 3.1647 1.00 2437 147 0.2404 0.2963 REMARK 3 6 3.1647 - 2.9782 1.00 2473 108 0.2420 0.3241 REMARK 3 7 2.9782 - 2.8291 0.99 2423 137 0.2589 0.3229 REMARK 3 8 2.8291 - 2.7060 0.99 2404 136 0.2698 0.3309 REMARK 3 9 2.7060 - 2.6020 0.99 2399 134 0.2972 0.3661 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.00 REMARK 3 SHRINKAGE RADIUS : 0.73 REMARK 3 K_SOL : 0.32 REMARK 3 B_SOL : 32.02 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.650 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.870 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.92 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.93930 REMARK 3 B22 (A**2) : -1.93930 REMARK 3 B33 (A**2) : 3.87860 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 3706 REMARK 3 ANGLE : 1.184 5019 REMARK 3 CHIRALITY : 0.082 555 REMARK 3 PLANARITY : 0.005 653 REMARK 3 DIHEDRAL : 18.289 1412 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3UIO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-NOV-11. REMARK 100 THE DEPOSITION ID IS D_1000068803. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23329 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.602 REMARK 200 RESOLUTION RANGE LOW (A) : 35.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.43900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1Z5S REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14% PEG4000, 100 MM SODIUM CITRATE PH REMARK 280 6.0, 200 MM AMMONIUM ACETATE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 279K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.29467 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 19.14733 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 19.14733 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 38.29467 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ASN B 14 REMARK 465 SER C 417 REMARK 465 LEU C 418 REMARK 465 THR C 419 REMARK 465 GLY C 420 REMARK 465 GLU C 421 REMARK 465 PRO C 422 REMARK 465 ALA C 423 REMARK 465 PRO C 424 REMARK 465 VAL C 425 REMARK 465 LEU C 426 REMARK 465 SER C 427 REMARK 465 SER C 428 REMARK 465 PRO C 429 REMARK 465 PRO C 430 REMARK 465 PRO C 431 REMARK 465 SER D 2629 REMARK 465 LYS D 2695 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 C GLY B 93 NZ LYS C 524 1.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 69 40.03 -95.56 REMARK 500 HIS A 83 140.67 -178.25 REMARK 500 LYS A 101 -84.19 -116.27 REMARK 500 GLN A 139 -70.22 -58.63 REMARK 500 GLU B 81 -0.48 67.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PRO A 157 SER A 158 132.36 REMARK 500 GLU D 2670 GLU D 2671 -146.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Z5S RELATED DB: PDB REMARK 900 RELATED ID: 3UIN RELATED DB: PDB REMARK 900 RELATED ID: 3UIP RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 VAL TO MET CONFLICT IN UNP ENTRY P61956 DBREF 3UIO A 1 158 UNP P63279 UBC9_HUMAN 1 158 DBREF 3UIO B 14 93 UNP P61956 SUMO2_HUMAN 14 93 DBREF 3UIO C 419 587 UNP P46060 RAGP1_HUMAN 419 587 DBREF 3UIO D 2631 2695 UNP P49792 RBP2_HUMAN 2631 2695 SEQADV 3UIO MET B 55 UNP P61956 VAL 55 SEE REMARK 999 SEQADV 3UIO SER C 417 UNP P46060 EXPRESSION TAG SEQADV 3UIO LEU C 418 UNP P46060 EXPRESSION TAG SEQADV 3UIO SER D 2629 UNP P49792 EXPRESSION TAG SEQADV 3UIO LEU D 2630 UNP P49792 EXPRESSION TAG SEQADV 3UIO VAL D 2642 UNP P49792 ALA 2642 ENGINEERED MUTATION SEQADV 3UIO GLU D 2644 UNP P49792 GLN 2644 ENGINEERED MUTATION SEQADV 3UIO LYS D 2647 UNP P49792 LEU 2647 ENGINEERED MUTATION SEQADV 3UIO ASP D 2649 UNP P49792 THR 2649 ENGINEERED MUTATION SEQADV 3UIO THR D 2650 UNP P49792 LYS 2650 ENGINEERED MUTATION SEQRES 1 A 158 MET SER GLY ILE ALA LEU SER ARG LEU ALA GLN GLU ARG SEQRES 2 A 158 LYS ALA TRP ARG LYS ASP HIS PRO PHE GLY PHE VAL ALA SEQRES 3 A 158 VAL PRO THR LYS ASN PRO ASP GLY THR MET ASN LEU MET SEQRES 4 A 158 ASN TRP GLU CYS ALA ILE PRO GLY LYS LYS GLY THR PRO SEQRES 5 A 158 TRP GLU GLY GLY LEU PHE LYS LEU ARG MET LEU PHE LYS SEQRES 6 A 158 ASP ASP TYR PRO SER SER PRO PRO LYS CYS LYS PHE GLU SEQRES 7 A 158 PRO PRO LEU PHE HIS PRO ASN VAL TYR PRO SER GLY THR SEQRES 8 A 158 VAL CSD LEU SER ILE LEU GLU GLU ASP LYS ASP TRP ARG SEQRES 9 A 158 PRO ALA ILE THR ILE LYS GLN ILE LEU LEU GLY ILE GLN SEQRES 10 A 158 GLU LEU LEU ASN GLU PRO ASN ILE GLN ASP PRO ALA GLN SEQRES 11 A 158 ALA GLU ALA TYR THR ILE TYR CSD GLN ASN ARG VAL GLU SEQRES 12 A 158 TYR GLU LYS ARG VAL ARG ALA GLN ALA LYS LYS PHE ALA SEQRES 13 A 158 PRO SER SEQRES 1 B 80 ASN ASN ASP HIS ILE ASN LEU LYS VAL ALA GLY GLN ASP SEQRES 2 B 80 GLY SER VAL VAL GLN PHE LYS ILE LYS ARG HIS THR PRO SEQRES 3 B 80 LEU SER LYS LEU MET LYS ALA TYR CYS GLU ARG GLN GLY SEQRES 4 B 80 LEU SER MET ARG GLN ILE ARG PHE ARG PHE ASP GLY GLN SEQRES 5 B 80 PRO ILE ASN GLU THR ASP THR PRO ALA GLN LEU GLU MET SEQRES 6 B 80 GLU ASP GLU ASP THR ILE ASP VAL PHE GLN GLN GLN THR SEQRES 7 B 80 GLY GLY SEQRES 1 C 171 SER LEU THR GLY GLU PRO ALA PRO VAL LEU SER SER PRO SEQRES 2 C 171 PRO PRO ALA ASP VAL SER THR PHE LEU ALA PHE PRO SER SEQRES 3 C 171 PRO GLU LYS LEU LEU ARG LEU GLY PRO LYS SER SER VAL SEQRES 4 C 171 LEU ILE ALA GLN GLN THR ASP THR SER ASP PRO GLU LYS SEQRES 5 C 171 VAL VAL SER ALA PHE LEU LYS VAL SER SER VAL PHE LYS SEQRES 6 C 171 ASP GLU ALA THR VAL ARG MET ALA VAL GLN ASP ALA VAL SEQRES 7 C 171 ASP ALA LEU MET GLN LYS ALA PHE ASN SER SER SER PHE SEQRES 8 C 171 ASN SER ASN THR PHE LEU THR ARG LEU LEU VAL HIS MET SEQRES 9 C 171 GLY LEU LEU LYS SER GLU ASP LYS VAL LYS ALA ILE ALA SEQRES 10 C 171 ASN LEU TYR GLY PRO LEU MET ALA LEU ASN HIS MET VAL SEQRES 11 C 171 GLN GLN ASP TYR PHE PRO LYS ALA LEU ALA PRO LEU LEU SEQRES 12 C 171 LEU ALA PHE VAL THR LYS PRO ASN SER ALA LEU GLU SER SEQRES 13 C 171 CYS SER PHE ALA ARG HIS SER LEU LEU GLN THR LEU TYR SEQRES 14 C 171 LYS VAL SEQRES 1 D 67 SER LEU ASP VAL LEU ILE VAL TYR GLU LEU THR PRO THR SEQRES 2 D 67 VAL GLU GLU LYS ALA LYS ALA ASP THR LEU LYS LEU PRO SEQRES 3 D 67 PRO THR PHE PHE CSD TYR LYS ASN ARG PRO ASP TYR VAL SEQRES 4 D 67 SER GLU GLU GLU GLU ASP ASP GLU ASP PHE GLU THR ALA SEQRES 5 D 67 VAL LYS LYS LEU ASN GLY LYS LEU TYR LEU ASP GLY SER SEQRES 6 D 67 GLU LYS MODRES 3UIO CSD A 93 CYS 3-SULFINOALANINE MODRES 3UIO CSD A 138 CYS 3-SULFINOALANINE MODRES 3UIO CSD D 2659 CYS 3-SULFINOALANINE HET CSD A 93 8 HET CSD A 138 8 HET CSD D2659 8 HETNAM CSD 3-SULFINOALANINE HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE FORMUL 1 CSD 3(C3 H7 N O4 S) FORMUL 5 HOH *143(H2 O) HELIX 1 1 ILE A 4 ASP A 19 1 16 HELIX 2 2 LEU A 94 GLU A 98 5 5 HELIX 3 3 THR A 108 GLU A 122 1 15 HELIX 4 4 GLN A 130 ASN A 140 1 11 HELIX 5 5 ASN A 140 PHE A 155 1 16 HELIX 6 6 LEU B 40 GLY B 52 1 13 HELIX 7 7 ASP C 433 PHE C 440 1 8 HELIX 8 8 SER C 442 ARG C 448 1 7 HELIX 9 9 LYS C 452 THR C 461 1 10 HELIX 10 10 ASP C 465 VAL C 479 1 15 HELIX 11 11 GLU C 483 ASN C 503 1 21 HELIX 12 12 ASN C 508 MET C 520 1 13 HELIX 13 13 LEU C 535 GLN C 548 1 14 HELIX 14 14 PRO C 552 ALA C 554 5 3 HELIX 15 15 LEU C 555 THR C 564 1 10 HELIX 16 16 ASN C 567 CYS C 573 1 7 HELIX 17 17 CYS C 573 VAL C 587 1 15 HELIX 18 18 THR D 2641 LYS D 2652 1 12 HELIX 19 19 THR D 2656 ARG D 2663 5 8 HELIX 20 20 ASP D 2676 LYS D 2683 1 8 SHEET 1 A 4 VAL A 25 LYS A 30 0 SHEET 2 A 4 MET A 36 PRO A 46 -1 O ASN A 37 N THR A 29 SHEET 3 A 4 LEU A 57 LEU A 63 -1 O MET A 62 N TRP A 41 SHEET 4 A 4 LYS A 74 PHE A 77 -1 O LYS A 76 N ARG A 61 SHEET 1 B 6 GLN B 65 PRO B 66 0 SHEET 2 B 6 ILE B 58 PHE B 62 -1 N PHE B 62 O GLN B 65 SHEET 3 B 6 THR B 83 GLN B 88 -1 O ASP B 85 N ARG B 61 SHEET 4 B 6 HIS B 17 ALA B 23 1 N LYS B 21 O ILE B 84 SHEET 5 B 6 VAL B 29 LYS B 35 -1 O PHE B 32 N LEU B 20 SHEET 6 B 6 VAL D2632 GLU D2637 -1 O TYR D2636 N GLN B 31 LINK C VAL A 92 N CSD A 93 1555 1555 1.34 LINK C CSD A 93 N LEU A 94 1555 1555 1.33 LINK C TYR A 137 N CSD A 138 1555 1555 1.33 LINK C CSD A 138 N GLN A 139 1555 1555 1.33 LINK C PHE D2658 N CSD D2659 1555 1555 1.33 LINK C CSD D2659 N TYR D2660 1555 1555 1.33 CISPEP 1 TYR A 68 PRO A 69 0 -2.98 CISPEP 2 GLU A 78 PRO A 79 0 1.97 CRYST1 151.351 151.351 57.442 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006607 0.003815 0.000000 0.00000 SCALE2 0.000000 0.007629 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017409 0.00000